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a b s t r a c t
Clinical and animal studies have documented that hearts of the elderly are more susceptible to ischemia/
reperfusion damage compared to young adults. Recently we found that aging-dependent increase in
susceptibility of cardiomyocytes to apoptosis was attributable to decrease in cytosolic glutaredoxin 1 (Grx1)
and concomitant decrease in NF-κB-mediated expression of anti-apoptotic proteins. Besides primary localiza-
tion in the cytosol, Grx1 also exists in the mitochondrial intermembrane space (IMS). In contrast, Grx2 is
conﬁned to the mitochondrial matrix. Here we report that Grx1 is decreased by 50–60% in the IMS, but Grx2 is
increased by 1.4–2.6 fold in the matrix of heart mitochondria from elderly rats. Determination of in situ
activities of the Grx isozymes from both subsarcolemmal (SSM) and interﬁbrillar (IFM) mitochondria revealed
that Grx1 was fully active in the IMS. However, Grx2 was mostly in an inactive form in the matrix, consistent
with reversible sequestration of the active-site cysteines of two Grx2 molecules in complex with an iron–sulfur
cluster. Our quantitative evaluations of the active/inactive ratio for Grx2 suggest that levels of dimeric Grx2
complex with iron–sulfur clusters are increased in SSM and IFM in the hearts of elderly rats. We found that the
inactive Grx2 can be fully reactivated by sodium dithionite or exogenous superoxide production mediated by
xanthine oxidase. However, treatment with rotenone, which generates intramitochondrial superoxide through
inhibition of mitochondrial respiratory chain Complex I, did not lead to Grx2 activation. These ﬁndings suggest
that insufﬁcient ROS accumulates in the vicinity of dimeric Grx2 to activate it in situ.
& 2013 The Authors. Published by Elsevier B.V.
Aging is a major risk factor for the development of ischemic
cardiovascular disease [1]. Previous studies in humans and animals
have shown that hearts of the elderly are more prone to oxidative
damage after ischemia/reperfusion (I/R) than their younger counter-
parts [2–4]. Therefore, a better understanding is necessary of how
changes with aging are linked to irreversible ischemic damage.
Reactive oxygen species (ROS) have been implicated in I/R injury,
directing research efforts towards the mitochondria [5]. Mitochondria
are the major source of ROS during cardiac I/R [6]. Accordingly,
protective mechanisms have involved blockade of the electron trans-
port chain (ETC) and modulation of the mitochondrial permeability
transition pore (MPTP) and other ion channels [7–9]. Further, defects
in mitochondrial activity have been associated with age-related
functional decline of organs and tissues [2,10].
The heart is equipped with antioxidant systems to scavenge
excess ROS and repair oxidative injury. Maintenance of sulfhydryl
homeostasis is vital and two enzyme systems play the key roles.
The thioredoxin (Trx)/thioredoxin reductase (TR) system and the
glutaredoxin (Grx)/glutathione (GSH/GSSG) reductase (GR)
systems maintain protein thiol status and regulate intracellular
signal transduction [11]. Trx mainly catalyzes the reduction of
protein intra-/inter-molecular disulﬁdes, whereas Grx speciﬁcally
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catalyzes reduction of protein-SS-glutathione mixed disulﬁdes
(deglutathionylation). Thus, the Trx and Grx systems operate in a
complementary fashion.
Two mammalian Grx isoforms (Grx1 and Grx2) catalyze deglu-
tathionylation. Grx1 is mainly cytosolic, but also exists in the
mitochondrial intermembrane space (IMS) [12]. Grx2 is localized
in the mitochondrial matrix. Unlike Grx1, mammalian Grx2 forms a
catalytically inactive dimer with an intercalating iron–sulfur cluster
[13]. The puriﬁed Grx2 dimer can be dissociated with GSSG or
sodium dithionite, yielding active monomers. Accordingly, Grx2 is
proposed to serve as a redox sensor in response to oxidative stress
[13], but evidence for this function in situ has not been reported.
The glutaredoxins have been implicated in cardiac health [14].
For example, H9c2 cells (model cardiomyocytes) that overexpress
Grx1 showed diminished H2O2-induced apoptosis attributed to
Grx1-mediated regulation of Akt activity [15]. S-glutathionylation
has been demonstrated to modulate activity of several ion chan-
nels important for cardiac function, implicating regulation by Grx1
[16,17]. In addition we characterized an anti-apoptotic regulatory
role for Grx1 in cardiomyocytes [18], as discussed further below.
As described, both Grx1 and Grx2 are present in the mitochon-
dria [12]. The estimated concentration of Grx2 in the matrix is
10-fold higher than the concentration of Grx1 in the IMS,
potentially compensating for the 10-fold lower catalytic activity
of Grx2 [19,20]. Grx2 overexpression was reported to attenuate
doxorubicin-induced cardiac injury, which is associated with
increased S-glutathionylation of mitochondrial proteins including
Complex I [21]. However, it remains to be determined whether
overexpressed Grx2 is representative of natural abundance of Grx2
which is largely sequestered in an inactive dimer [55], and
whether mitochondrial Grx1 plays a cardioprotective role.
Previously, our lab studied the effects of aging on cardiac redox
homeostasis, ﬁnding that Grx1, was decreased 40% in cardiomyocytes
isolated from elderly (24-mo) Fischer 344 rats (aging model animals),
compared to young adults (6-mo), whereas the thioredoxin system
was essentially unchanged. The decrease in Grx1 was correlated with
decreased NF-κB transcriptional activity and diminution of expression
of its anti-apoptotic gene product, Bcl-xL [18]. Analogous changes to
NF-κB and its target genes were observed in H9c2 cells in which Grx1
was selectively knocked down to the same extent as observed in the
hearts of the elderly rats [18].
Here we report that mitochondrial Grx1 and Grx2 are altered
differently with aging. Whereas Grx1 content and corresponding
activity is decreased in the intermembrane space of mitochondria
from elderly Fischer 344 rat hearts, Grx2 content is increased in
the matrix compared to young adults. However, the major portion
of the Grx2 in situ is in an inactive state, consistent with
sequestration as a dimeric iron–sulfur cluster complex. The inac-
tive Grx2 in mitochondrial lysates could be reactivated by a
superoxide generating system. However, the deglutathionylase
activity of Grx2 was not increased by treatment of intact mito-
chondria with rotenone, which is known to stimulate matrix-
directed intramitochondrial generation of ROS via inhibition of
Complex I [22]. This ﬁnding is inconsistent with the concept that
dimeric Grx2 serves as a redox sensor, dissociating into active
monomers in response to oxidative stress.
Experimental procedures
General materials
L-Cysteine–glutathione mixed disulﬁde (Cys-SSG) was purchased
from Toronto Research (Canada, C995500). Mn-TMPyP (Mn(III)
tetrakis (1-methyl-4-pyridyl) porphyrin, tetratosylate, hydroxide)
was purchased from EMD Millipore Chemicals. Xanthine oxidase
was purchased from Roche Applied Science. Soybean trypsin and
trypsin inhibitor were purchased from Worthington Biochemical
Corporation. All other chemicals were purchased from Sigma (St.
Louis, MO). Recombinant human BID, Caspase-8-cleaved/truncated
BID (t-Bid) was purchased from R&D Systems, Minneapolis, MN.
Anti-human Grx1 polyclonal antibody (1:1000 dilution) was gener-
ated and puriﬁed via an adaptation of the McKinney and Parkinson
caprylic acid method [23]. Anti-human Grx2 polyclonal antibody
was kindly provided by Dr. Vadim Gladyshev (1:1000 dilution).
Rabbit anti-adenylate kinase 2 polyclonal antibody (1:1000 dilution)
was purchased from Abcam and mouse anti-cytochrome c mono-
clonal antibody (1:1000 dilution) from BD Pharmingen, San Diego,
CA. Anti-rabbit and anti-mouse secondary antibodies conjugated to
HRP were purchased from Jackson Immuno Research Labs (1:10,000
dilutions).
Animals
Young adult (6-mo) and elderly (24-mo) male Fischer 344 rats
were purchased from the National Institute on Aging's colonies
(Harlan, Indianapolis, IN; Taconic, Germantown, NY) and housed in
the animal facilities at Case Western Reserve University School of
Medicine. Animals were acclimated for at least 1 week before use,
and used for experiments within 3 months. The Institutional
Animal Care and Use Committee at Case Western Reserve
University approved all animal handling procedures and
experiments.
Isolation and preparation of heart mitochondria
The isolation of subsarcolemmal mitochondria (SSM) and
intraﬁbrillar mitochondria (IFM) from Fischer 344 rat hearts was
performed as previously described [12] with slight modiﬁcations
to improve the quality of the IFM. Brieﬂy, the polytron homo-
genate was centrifuged at 500 g and the pellet saved in order to
isolate the IFM fraction. The pellet was resuspended in Chappel–
Perry buffer (100 mM KCl, 50 mM Mops, 5 mM MgSO4, 1 mM
EGTA, 1 mM ATP, pH 7.4) containing trypsin (5 mg/g of heart
tissue) and incubated for 10 min on ice. This solution was homo-
genized and then the trypsin activity was blocked by the addition
of Chappel–Perry buffer plus 0.2% defatted BSA and trypsin
inhibitor (2.5 mg/g of heart tissue). After centrifugation at
600 g to remove unbroken tissue and debris, the supernatant
was centrifuged at 3000 g to sediment the IFM fraction. This
fraction was washed twice thereafter by centrifugation at 3000 g
for 10 min. Mitochondrial protein concentrations were determined
either by the bicinchronic acid (BCA) method (using the micro BCA
protein assay kit, Thermo-Scientiﬁc, Waltham, MA) or the Lowry
method [24]. Mitochondria were analyzed within 8 h of their
isolation from tissues.
Mitochondrial thioredoxin and thioredoxin reductase activity assays
Isolated heart mitochondria were homogenized at 4 1C in 1 mL
buffer (10 mM potassium phosphate, pH 7.5; 5 mM EDTA; 50 μM
PMSF; and 2 mM β-mercaptoethanol) using a glass homogenizer. The
homogenates were centrifuged at 10,000 g for 10 min at 4 1C.
Supernatants were dialyzed to remove free GSH at 4 1C against the
same buffer using a ratio of 1 mL supernatant to 1000 mL dialysis
buffer. Dialysis was performed overnight with one change of buffer,
and then the dialyzed mitochondrial extract was assayed the next
day for total dethiolase activity [25]. Brieﬂy, the reactionwas initiated
by adding BSA-SSG [35S] (0.1 mM) to an aliquot of dialyzed mito-
chondrial extract in potassium phosphate buffer (0.1 M, pH 7.5), with
a total volume of 500 μL. At 0, 2, 4 and 6 min, 100 μL aliquots were
removed and mixed with 100 μL of ice-cold trichloroacetic acid
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(20%). After centrifugation at 10,000 g, the supernatants from each
time point were analyzed for [35S] radioactivity by scintillation
counting. Dethiolase activity is expressed as nmol [35S]
GS-equivalents released per min/mg of heart mitochondrial protein,
according to the speciﬁc radioactivity of the GS-moiety of BSA-SSG
[35S] (0.7 μCi/mmol GS-moiety). Thioredoxin reductase activity
was measured using a modiﬁcation of this dethiolase assay, as
previously described [26]. Brieﬂy, an aliquot of mitochondrial homo-
genates was transferred into the assay mixture containing 0.2 mM
NADPH, 2.1 μM (0.04 unit) thioredoxin and 0.1 M potassium phos-
phate buffer, pH 7. The assay reaction was initiated by addition of
2 mM hydroxyethyldisulﬁde (HED).
Mitochondrial GSSG reductase activity assay
Mitochondrial GSSG reductase activity was determined based
on the methods as described [26]. Brieﬂy, mitochondrial lysate
(40–100 μg) was incubated in reaction buffer containing Na/K
phosphate buffer (0.1 mM, pH 7.5), and 0.2 mM NADPH at 30 1C for
5 min. The reaction was initiated by the addition of 0.1 mM GSSG
and the oxidation of NADPH was monitored at 340 nm for 5 min
using a ThermoMaxs microplate reader (Molecular Devices Inc.).
Mitochondrial oxidative phosphorylation assays
Oxygen consumption was measured with a Clark-type elec-
trode in respiration buffer (80 mM KCl, 50 mM Mops, 1 mM EGTA,
5 mM KH2PO4 and 1 mg/mL defatted BSA, pH 7.4 and ﬁnal volume
0.5 mL) [27,28] at 30 1 C with glutamate (20 mM) as substrate.
After depletion of endogenous substrates with 100 μM ADP, State
3 respiratory rate (ADP-dependent) was measured in the presence
of 200 μM ADP and State 4 respiratory rate (ADP-limited) was
recorded after ADP consumption. Then sequential additions of
2 mM ADP and 200 μM of the uncoupler 2,4-dinitrophenol (DNP)
were made, as described [29]. Respiratory control ratios (RCR,
deﬁned as State 3 respiratory rate divided by State 4 respiratory
rate) reﬂects the control of oxygen consumption by phosphoryla-
tion or “coupling”. The ADP/O ratio, deﬁned as the number of ADP
molecules added for each oxygen atom consumed, is an index of
the efﬁciency of oxidative phosphorylation, and was calculated as
described by Chance and Williams [30].
Western blot analysis of Grx1 and Grx2 content in F344 rat heart
mitochondria
In order to release Grx1 from the intermembrane space of
mitochondria of the SSM and IFM fractions isolated from Fischer
344 rats (6-mo and 24-mo), the mitochondrial preparations were
washed once with cold KME buffer (100 mM KCl, 50 mM MOPS,
0.5 mM EGTA, pH 7.4) and centrifuged at 5400 g to remove any
proteins released from non-intact mitochondria and cytosolic con-
tamination in the mitochondrial preparations, then the mitochon-
dria were diluted with KME buffer to a concentration of 20 mg/mL,
and incubated at 37 1C with or without t-Bid (45 nM) for 1 h, and
centrifuged at 3500 g for 10 min at 4 1C. The resulting supernatant
containing the soluble intermembrane space proteins was saved as
“supernatant”. The pellets were washed twice and resuspended in
100 mL of RIPA buffer (150 mM NaCl, 1 mM EGTA, 1% Triton X-100,
25.5 mM deoxycholic acid, 50 mM Tris–HCl, pH 7.5), incubated
on ice for 10 min, and centrifuged at 10,000 g for 15 min. The
resulting supernatant was saved as “mitochondrial extract.” The
residual pellets were washed twice with RIPA buffer following a
centrifugation at 12,000 g to precipitate insoluble proteins as
“residue”. Equal volumes of each sample were analyzed by Western
blot as previously described [12].
Electron microscopy
Cardiac tissues from young adult (6-mo F344) and elderly (24-
mo F344) hearts were ﬁxed for 5 min at 4 1C with 3% formaldehyde
and 20 mM Methylacetimidate in HEPES-buffered saline (30 mM
HEPES, 150 mM NaCl, 4.7 mM KCl, 1.2 mM MgCl2, 7.8 mM glucose,
pH 7.3). These samples were washed, further ﬁxed for 45 min in 3%
formaldehyde containing 0.25% glutaraldehyde in HEPES-buffered
saline at 4 1C, then dehydrated in ethanol and embedded in LR
White resin (Polysciences, Inc., Warrington, PA). Thin sections were
blocked with PBT (PBS containing 1% w/v BSA and 0.01% v/v Tween
20). Grids were then incubated with anti-human GRx1 polyclonal
antibody at 1:5 and 1:25 dilution, respectively, in PBT for 12 h at
4 1C. After washing, grids were incubated for 1 h in 5 nM gold-
conjugated anti-rabbit IgG (Amersham Life Sciences, Arlington, IL)
diluted 1:30 in PBT, rinsed with PBS, and ﬁxed with glutaraldehyde
to stabilize the gold particles. Samples were stained with uranyl
acetate and lead citrate, and then examined in a JEOL 1200EX
electron microscope (Tokyo, Japan).
Standard Grx activity assay
The coupled spectrophotometric assay to determine Grx spe-
ciﬁc activity was performed as described previously [31,32].
Reaction mixtures containing Na/K phosphate buffer (0.1 mM,
pH 7.5), NADPH (0.2 mM), yeast GSSG reductase (6 unit/mL), GSH
(0.5 mM), and puriﬁed human Grx1 or mitochondrial lysates (2 mg
of total protein) were added to a 96-well plate and incubated for
5 min at 30 1C. GSH-dependent deglutathionylation reactions were
initiated by the addition of Cys-SSG (0.1 mM) as the substrate. The
oxidation of NADPH was monitored at 340 nm for 4 min using
a Thermo Max microplate reader (Molecular Devices). Non-
enzymatic rates of NADPH oxidation (RIPA buffer with 1 mM
GSH or 10 mM sodium dithionate) were subtracted from observed
rates of NADPH oxidation using mitochondrial lysates to give the
rates of deglutathionylation, corresponding to the speciﬁc activity
of Grx. The number of nanomoles of NADPH oxidized per minute
(nmol/min) was calculated using the standard extinction coefﬁ-
cient of NADPH (ε¼6.22 A/mM/cm). This value was then divided
by the total amount of protein added in the assay giving nmol/
min/mg of mitochondrial protein, and corrected for differences in
path length and extinction coefﬁcient for the microplate reader
compared to a standard spectrophotometer. For all analyses, Grx
activity was calculated using an amount of mitochondrial lysate
where the reaction rates fell within the linear range of dependence
on the concentration of Grx.
Measurements indicative of in situ Grx activities in heart
mitochondria of 6-mo and 24-mo Fischer 344 rats
In order to simplify the Grx activity assay to determine the
speciﬁc Grx2 activity in mitochondrial lysates, isolated mitochon-
drial fractions (4 mg) without the t-Bid treatment were centri-
fuged at 5500 g at 4 1C to remove KME buffer, and the pellets
lysed using RIPA buffer (400 μL), containing either 1 mM GSH or
10 mM sodium dithionate, to achieve a ﬁnal protein concentration
of 10 mg/mL. The reaction mixtures were incubated at room
temperature for 40 min followed by centrifugation at 21,000 g
for 10 min at 4 1C to precipitate mitochondrial debris. The resul-
tant supernatants, containing Grx1 and Grx2 from the lysates,
were saved. The pellets were then resuspended in RIPA buffer
(150 μL, with either 1 mM GSH or 10 mM dithionite) in order to
extract the remaining Grx from the mitochondrial debris. After a
centrifugation at 21,000 g for 10 min at 4 1C, the insoluble pellets
were removed. The saved supernatants were combined and 2 mg
of mitochondrial protein from each sample were concentrated
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using centrifugal ﬁlter devices (Amicon-ultra 0.5 mL 10,000 MW,
EMD Millipore) at 14,000 g for 10 min at 4 1C. For all analysis, the
speciﬁc Grx2 activity was calculated as the observed activity after
GSH or dithionite treatment minus the Grx1 activity which was
calculated from previously established Grx1 contents for mito-
chondria from each age group of animals.
Several of the conditions necessary for successful isolation and
analysis of the heart mitochondria were found to alter the
Standard Grx Activity Assay. In order to account for this, several
correction factors were necessary to normalize the results from
these samples to previous Grx activity data. The addition of RIPA
buffer (the medium in which mitochondrial extracts were pre-
pared) was found to increase Grx activity by a factor of 1.67.
Results were therefore divided by 1.67 to account for this differ-
ence. Sodium dithionite was found to inhibit GSSG reductase,
thereby interfering with the Standard Grx Activity Assay. This was
overcome by increasing the concentration of GSSG reductase
3-fold, with the residual effect adjusted by a factor of 1.1.
Reduction of mitochondrial cytochromes by differential ROS
production system
Liver mitochondria were isolated from young adult Fischer 344
rats and prepared as described before [27]. Aliquots (4 mg) of
frozen liver mitochondria were centrifuged at 5500 g to remove
the KME buffer from the resulting pellets. The pellets were lysed
with RIPA buffer (200 μL), and then supplemented with sodium
cyanide (2 mM). After centrifugation at 21,000 g for 10 min at 4 1C
to remove the mitochondrial debris, reduction of the cytochromes
was carried out in ROS-generating mixtures containing 10 mg/mL
mitochondrial lysates, 1 mM GSH, 10 μM xanthine oxidase and
2 mM xanthine, in the presence of either catalase (1 mg/mL), or
Mn-TMPyP (SOD mimetic, varying concentration). After 10 min
incubation at room temperature, each treated or untreated sample
was subjected to spectrophotometric analysis by recording the
absorption spectra between 500 and 660 nm (HP 8453 UV–VIS).
Dissociation of dimeric Grx2 by different ROS production systems
Freshly isolated mitochondria (4 mg) from young adult Fischer
344 rat hearts were centrifuged at 5500 g to remove the KME
buffer. The pellets were lysed in RIPA buffer (400 μL) containing
either 1 mM GSH, or 10 mM dithionite. After a 30 min incubation
at 25 1C, the mitochondrial lysate was mixed with xanthine
oxidase (10 μM) and xanthine (2 mM), in the presence of either
catalase (1 mg/mL) or Mn-TMPyP (40 μM). This was incubated for
an additional 10 min followed by centrifugation at 21,000 g at
4 1C to precipitate the debris. The pellets were rinsed and fully
resuspended in of RIPA buffer (120 μL, with 1 mM GSH or 10 mM
dithionite), and centrifuged again at 21,000 g. The supernatants
from both 21,000 g spins were combined and concentrated
through a centrifugal ﬁlter. A portion (2 mg) of the concentrated
supernatants was subjected to the Standard Grx Activity Assay,
using appropriate correction factors. The addition of RIPA buffer
and xanthine oxidase were found to increase recombinant Grx1
activity by a factor of 2.08, and samples containing RIPA buffer,
xanthine oxidase, and catalase increased the activity by a factor
of 2.32.
Intramitochondrial superoxide anion production by
rotenone-mediated inhibition of Complex I
To induce endogenous mitochondrial superoxide generation,
heart mitochondria (8 mg) isolated from either young adult or
elderly Fischer 344 rats were incubated with glutamate (20 mM)
in the presence or absence of rotenone (7.5 μM) for 20 min
at 37 1C. The samples were then centrifuged at 5500 g and the
pellets were washed by the addition of KME buffer to remove
excess glutamate and rotenone, and then lysed with RIPA buffer
(volume adjusted to 10 mg/mL mitochondrial protein) containing
either 1 mM GSH or 10 mM dithionite for 30 min. The mitochon-
drial lysates were then centrifuged at 21,000 g for 10 min at 4 1C
to precipitate the mitochondrial debris. The insoluble pellets were
then resuspended in RIPA buffer (150 μL) and re-centrifuged at
21,000 g. The supernatants were combined and concentrated
through centrifugal ﬁlter devices at 14,000 g for 10 min at 4 1C.
An equal amount (2 mg) of the concentrated proteins was ana-
lyzed using the Standard Grx Activity Assay.
Statistical analysis
Data are presented as mean7standard error (mean7SEM) of
at least three independent experiments. On occasion when an
individual data point was more than two standard deviations from
the mean, it was considered to be an outlier and was omitted.
Differences between data sets were tested for statistical signiﬁ-
cance using 2-tailed Student's t-test (Microsoft Excel), with
po0.05 considered statistically signiﬁcant.
Results
Examination of heart mitochondria for changes in the thioredoxin
and glutaredoxin systems in elderly animals
Our previous studies revealed that cytosolic Grx1 from heart
tissues was signiﬁcantly decreased in elderly rats (50%) decrease
in content and activity), compared to young adult rats. In contrast,
little change was observed in cytosolic thioredoxin (Trx), Trx
reductase (TR) or GSSG reductase [18]. Mitochondria are the
primary source of ROS, and the ROS production is increased in
mitochondria from elderly animals [9,33–35]. The goal of this
project was to assess age-related changes to the two mitochon-
drial anti-oxidant systems responsible for thiol homeostasis, Trx
and Grx. In the heart there are two populations of mitochondria,
the subsarcolemmal mitochondria (SSM) and the interﬁbrillar
mitochondria (IFM) characterized with distinct biochemical prop-
erties and responses to metabolic challenges [36]. We monitored
the rates of oxidative phosphorylation in the mitochondria from
both the SSM and IFM to verify the integrity and quality of the
isolated mitochondria (Table 1). The uncoupled respiratory rates
were similar to previous reports [36,37], indicating that the
isolated mitochondria for the current study have normal maximal
respiratory capacity. Moreover, unlike Complex I (Table 1B) the
oxidative metabolism through Complex III was signiﬁcantly
decreased selectively in heart IFM from elderly rats at respiratory
state 3, as we reported previously [38] (Table 1C), conﬁrming the
aging-associated defects in the electron transport chain that we
had characterized.
The activities of Trx2 and Trx reductase-2 were assessed in
both populations of heart mitochondria from young adult (6-mo)
and elderly (24-mo) Fischer 344 rats. We found the activities of
these enzymes in both IFM and SSM were not signiﬁcantly
different for the young adult and elderly rats (Table 2). Data for
GSSG reductase (GR) are also shown in Table 1. Again we found the
GR activities in both IFM and SSM were not signiﬁcantly different
for the young adult and elderly rats, although there was a trend
toward a small increase in the SSM (Table 2).
Next we focused on the mitochondrial glutaredoxins. In mam-
malian cells two dithiol isoforms of Grx1 and Grx2 have been
characterized and found to have distinct localizations within the
subcompartments of the mitochondria [12,31]. Mitochondrial
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Grx1 is present exclusively in the intermembrane space (IMS),
segregated from Grx2, which is located in the mitochondrial
matrix. We used t-Bid to selectively release Grx1 from the IMS
[12], leaving Grx2 in the mitochondrial matrix. This allowed us to
quantify the content and activity of Grx1 and Grx2 separately.
Accordingly, heart mitochondria from young adult and elderly rats
were treated with t-Bid, fractionated, and then analyzed by
Western blot to determine the protein content of Grx1 and Grx2,
as shown for the SSM (Fig. 1A and B); analogous results were
observed for the IFM (data not shown). We found that Grx1 was
fully released from the mitochondria, with no Grx1 detectable in the
mitochondrial extracts or residues after t-Bid treatment. In addition
to Grx1, adenylate kinase 2 (AK-2), an established biomarker for IMS
localization, was also fully released by t-Bid. As expected, cytochrome
c which exists in bound and free forms in the IMS was only partially
released as we observed before [12]. Grx2 was not released by the t-
Bid treatment, remaining with the mitochondrial extract (matrix
fraction). These results are consistent with our previous report of
mitochondrial Grx1 as a t-Bid-releasable protein located in the IMS,
and Grx2 localized to the matrix [12].
We found an age-associated decrease in Grx1 content in both
the SSM (50%) and the IFM (60%) (Fig. 2A and B). Corroborat-
ing the diminution of Grx1 in the IMS in situ, we used immuno-
cytochemistry with gold particles and electron microscopy to
localize and quantify the Grx1 in isolated heart mitochondria
(Fig. 2C and D). Thus, fewer gold particle-conjugated Grx1 anti-
bodies were observed in the outer compartment and contiguous
intracristal space (IMS) of the mitochondria isolated from an
elderly rat as compared to young adult. The extent of diminution
of Grx1 in the IMS is comparable to the diminution of Grx1 that we
observed previously in the cytosol [18], suggesting that the
content of Grx1 undergoes dynamic equilibration between the
cytosol and IMS during aging (see Discussion section). In contrast,
the content of Grx2 was increased in the SSM (1.4-fold) and more
substantially in the IFM (2.6-fold) from elderly rats as compared to
young adult rats (Fig. 3A and B), suggesting different regulatory
mechanisms governing the contents of mitochondrial Grx1 and
Grx2. We next investigated whether the changes in Grx1 and Grx2
content corresponded to changes in their catalytic deglutathiony-
lase activities.
After separating Grx1 with t-Bid, the fraction containing Grx2 was
then lysed, and both fractions were assayed for Grx activity. Based on
their contents and their respective speciﬁc activities, the expected
deglutathionylase activities for Grx1 and Grx2 were calculated
(predicted), and compared to the observed activities (Table 3). The
observed activities for Grx1 from SSM and IFM corresponded well to
Table 2
Activities of thioredoxin, thioredoxin reductase and GSSG reductase in heart
mitochondria of youn][g adult and elderly Fischer 344 rats.
Activity SSM IFM
6-mo 24-mo 6-mo 24-mo
Trx 0.3870.04 0.4670.04 0.4570.07 0.4670.04
Trx reductase 10.271.9 11.370.7 9.971.7 9.671.1
GSSG reductase 7.470.9 8.971.4 8.971.6 9.270.6
The activities of thioredoxin (Trx), thioredoxin reductase and GSSG reductase were
measured in the SSM and IFM from both young adult (6–8 mo) and elderly (24–28
mo) F344 rat hearts, as described under Experimental procedures section. Values
represent the mean7SEM for duplicate assays of at least three separate biological
samples (n43) and are expressed as nmol/min/mg of mitochondrial protein.
Table 1
Protein yield (A) and respiratory rates (B) and (C) in heart SSM and IFM from adult (6-mo) and elderly (24-mo) F344 rats.
F344 rats (age) 6-mo 24-mo
A
Heat mitochondrial fractions SSM IFM SSM IFM
Protein yield (mg/mL) 2070.9 1970.7 1870.7 1570.4
B
Glutamate-supported mitochondrial OXPHOS State 3 State 4 RCR ADP/O 2 mM ADP DNP
6-mo
SSM 159712.2 1373.5 1572.6 2.8670.11 169718.3 164713.1
IFM 240720.3 2173.5 1372.6 2.8770.08 259725.0 251731.8
24-mo
SSM 162 79.4 1472.0 1372.0 2.8470.10 169713.5 160714.7
IFM 195 710.8 1972.4 1171.3 2.9070.10 210715.7 211721.0
P values (6-mo vs. 24-mo)
SSM 0.837 0.89 0.521 0.878 0.991 0.825
IFM 0.058 0.645 0.443 0.768 0.10 0.282
C
DHQ-supported mitochondrial OXPHOS State 3 State 4 RCR ADP/O 2 mM ADP DNP
6-mo
SSM 382720.7 8874.6 470.2 1.6570.08 354716.9 443734.4
IFM 5497 23.6 106710.0 570.5 1.7470.14 536729.5 630724.9
24-mo
SSM 398720.1 9274.1 470.2 1.6370.10 396721.2 476735.3
IFM 442727.2 10979.9 470.1 1.6970.10 451718.5 567751.1
P values (6-mo vs. 24-mo)
SSM 0.572 0.459 0.893 0.872 0.125 0.476
IFM *0.009 0.788 *0.018 0.756 *0.024 0.251
SSM and IFM were isolated from F344 rats as described in Experimental procedures section. The uncoupled respiratory rates
(B) were determined using glutamate (20 mM) as Complex I substrate, (C) and duroquinol (DHQ) (1 mM) as Complex III
substrate. The protein concentration of isolated mitochondria is expressed as mg/g heart wet weight (mean7SEM, n¼6);
the respiratory rate is expressed as nAO per min/mg of mitochondrial protein (mean7SEM, n¼6). RCR-respiratory control
ratio; DNP-dinitrophenol uncoupled respiration.
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the predicted activities for both young adult and elderly rats. Thus,
Grx1 activity was decreased in the heart mitochondria from the
elderly rats in parallel to the decrease in content. The activities for
Grx2 for the same mitochondria from elderly rats, however, corre-
sponded to only a fraction of the predicted activities based on Grx2
protein content. This result suggested that the activity of Grx2 was
partially inhibited or suppressed in the mitochondrial matrix.
Grx2 activity can be fully realized with dithionite treatment
Previous studies have documented that a number of glutar-
edoxins, including mammalian Grx2, are capable of incorporating
an iron–sulfur center [13,39]. Using structural protein analysis, it
was determined that four cysteine residues contribute thiolate
ligands to the iron–sulfur [Fe2S2] cluster; two are from GSH
molecules and two from human Grx2 monomers (N-terminal
catalytic Cys76) [40]. Biochemical characterizations of puriﬁed
dimeric human Grx2 demonstrated that addition of GSH stabilizes
but GSSG or sodium dithionite promote dissociation of the com-
plex [13,41], as illustrated in Fig. 4 (panel A). We hypothesized that
the less than predicted activity of Grx2 in the Grx Standard Assay
is due to at least partial persistence of inactive Grx2 dimer bound
to the iron–sulfur cluster, reﬂecting its natural existence in the
mitochondrial matrix.
To test this hypothesis, the heart mitochondria, after t-Bid treat-
ment to remove Grx1, were lysed in RIPA buffer in the presence of
either GSH (1 mM) to preserve the inactive complex, or sodium
dithionite (10 mM) to dissociate the Grx2 monomers from the iron–
sulfur cluster complex and reactivate the enzyme. These pre-treated
mitochondrial lysates containing only Grx2 were then assayed for
deglutathionylase activity by modiﬁcations of the Grx Standard Assay
(see Experimental procedures section). Treatment with GSH main-
tained the limited Grx2 activity from the SSM (13%) and IFM (27%)
matrix fractions from the hearts of the elderly animals. In contrast,
when the lysates were treated with dithionite, the activity of Grx2
was essentially fully restored to the predicted values for both mito-
chondrial populations (Fig. 4B). These data suggest that most of the
mitochondrial Grx2 in the hearts of elderly animals exists in the
inactive dimeric complex, and this assessment is in good agreement
with earlier results that used different techniques in vitro and in vivo to
estimate the extent of sequestration of Grx2 in the iron–sulfur
complex [13,42]. Our ﬁndings represent the ﬁrst determinations of
Grx2 activity in situ and provide a new analytical approach to assess
the potential physiological roles of Grx2 in mitochondria.
Fig. 1. Western blot analysis of Grx1 and Grx2 content in the SSM from young adult and elderly Fischer 344 rat hearts. Heart SSM isolated from young adult and elderly F344
rats were treated with t-Bid to release the Grx1 localized in the mitochondrial intermembrane space. Subsequent mitochondrial fractionations resulted in “Supernatant,”
“Mitochondrial Extract,” and “Residues” fractions, as described in detail previously [12]. Each fraction was analyzed for Grx1, Grx2, Ak-2 and cytochrome c by Western blot.
The content of Grx1 and Grx2 was quantiﬁed by comparing the density of the bands to a standard curve generated on each gel using the corresponding puriﬁed human
isozymes. Representative Western blots from (A) young adult and (B) elderly rat heart SSM fractions.
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Quantitative evaluations of in situ Grx2 monomer and dimer
in mitochondria from young adult and elderly rat hearts
Selective quantiﬁcation of Grx2 activity in situ was then used to
estimate the monomeric and dimeric distribution of Grx2 in the
heart mitochondria of young adult versus elderly rats. Consistent
with the aforementioned results (Fig. 4B), limited Grx2 deglu-
tathionylase activity was maintained by lysis in the presence of
GSH, but essentially full activity was realized in most cases upon
treatment with sodium dithionite (Fig. 4C and D), although the
experimental variation between predicted and observed values
was larger for the IFM (Fig. 4D).
Fig. 2. Mitochondrial Grx1 content is decreased in both populations of heart mitochondria from elderly Fischer 344 rats. Mitochondrial Grx1 contents in the SSM and IFM
from young adult and elderly F344 rat heart tissues were determined by interpolation of the band density of t-Bid-released Grx1, using a standard curve relating the
densities of the bands of several different amounts of puriﬁed human Grx1 protein that were analyzed on the same gels in each respective case, as described previously [12].
The values are reported as ng Grx1 per mg of mitochondrial protein (mean7SEM, n¼5) for (A) SSM and (B) IFM. Diminutions of Grx1 content were observed in the IFM and
SSM from the elderly rats compared to the young adult rats. The diminution of mitochondrial Grx1 content in the elderly F344 rat hearts was corroborated using gold
labeling of Grx1 antibodies based on electron microscopy analysis (C) and (D). Black arrows indicate Grx1 localization in the outer mitochondrial compartment
(intermembrane space) of heart mitochondria from (C) young adult and (D) elderly F344 rats. Twenty-two gold particles were counted in the mitochondrial sample from
young adult rats, compared to ten that were observed in the sample from the elderly rats.
Fig. 3. Grx2 content is increased in heart SSM and IFM from elderly Fischer 344 rats. Grx2 contents in heart (A) SSM and (B) IFM from 6-mo and 24-mo rats were processed
and analyzed in a blinded fashion. Grx2 contents in the matrix fractions from the mitochondrial samples were analyzed by Western blot, using anti-Grx2 antibodies as
described previously [12]. The reported values were determined by interpolation of the densities of Grx2 bands into standard curves relating the densities of the bands of
several different amounts of puriﬁed human Grx2 protein that were analyzed on the same gels in each respective case. The values reported are expressed as ng Grx2 per mg
mitochondrial protein (mean7SEM, n¼5).
X.-H. Gao et al. / Redox Biology 1 (2013) 586–598592
Table 3
Age-associated changes in mitochondrial Grx1 and Grx2 activities.
SSM
Predicted activity Observed activity
6-mo 24-mo 6-mo 24-mo
Grx1 0.1 0.05 0.1070.003 0.06270.004
Grx2 0.23 0.34 0.1370.002 0.1670.004
IFM
Predicted activity Observed activity
6-mo 24-mo 6-mo 24-mo
Grx1 0.115 0.042 0.1070.004 0.06570.014
Grx2 0.21 0.55 0.1570.005 0.1770.025
The deglutathionylation activities (predicted according to speciﬁc
protein content, and observed) of Grx1 and Grx2 in the (A) SSM and
(B) IFM from young adult and elderly F344 rat hearts represent the
mean7SEM for at least duplicate assays of at least three separate
biological samples (n43), expressed as nmol/min/mg of mitochon-
drial protein. The predicted activities of Grx1 and Grx2 were
calculated based on the protein content of these enzymes in each
mitochondrial population, see Fig. 1, and using the speciﬁc activity
of each enzyme [31,32].
Fig. 4. Grx2 is present as a dissociable dimeric iron-sulfur cluster complex. (A) Grx2 exists in an inactive dimeric form where the catalytic cysteine (Cys76) of each of the two
monomeric Grx2 molecules is ligated reversibly to an iron moiety of the [Fe2S2] cluster. Two GSH molecules also serve as ligands. Diminution of GSH in the solution causes
partial dissociation of the complex, and treatment with sodium dithionite (DT) results in full dissociation, resulting in release of two active Grx2 monomers. Superoxide
radicals also are predicted to dissociate this complex, leading to activation of Grx2 under oxidative stress conditions, suggesting that the iron–sulfur cluster-bound Grx2 may
function as a redox sensor in vivo [13,57]; (B) The Grx2 complex can be stabilized by mitochondrial lysis in the presence of GSH, or fully activated by sodium dithionite
treatment. Following t-Bid treatment of mitochondria isolated from elderly F334 rats to release Grx1, lysates of t-Bid-treated mitochondria were analyzed for Grx2 activity
(nmol/min/mg of mitochondrial protein). The mitochondrial lysates were adjusted to include either GSH (1 mM, white bars) or sodium dithionite (DT, 10 mM, black bars).
The corresponding values were compared to the predicted Grx2 activity, calculated on the basis of the Grx2 content and its speciﬁc activity [31] (diagonal bar). Data
represent mean7SEM, n¼3; (C) and (D) Quantitative evaluation of the contribution of Grx2 to the deglutathionylation activities of (C) SSM and (D) IFM from the hearts of
young adult and elderly F344 rats. Isolated heart SSM and IFM from young adult and elderly rats were lysed in RIPA buffer supplemented with either GSH (1 mM, white bar)
or sodium dithionite (DT, 10 mM, black bar). The total deglutathionylation activity was then determined and the contribution of Grx2 in each case was calculated by
subtracting the amount of activity attributable to Grx1 according to its known content and corresponding activity measured in previous separate experiments. Results for
Grx2 are reported as mean (nmol/min/mg mitochondrial protein)7SEM (n¼5 for young adult animals and n¼8 for elderly animals). The values for observed Grx2 activities
are compared to the predicted Grx2 activities (diagonally hatched bar), calculated from the previously determined Grx2 contents and the GRx2 speciﬁc activity.
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Overall, both the content and the activity of mitochondrial Grx1
are decreased in the hearts of the elderly, whereas the content and
activity of Grx2 are increased. However, in both young adults and
elderly rats the majority of the heart mitochondrial Grx2 is
inactive, likely sequestered in its dimeric iron–sulfur complex
(see Discussion section).
Exogenous superoxide production by xanthine oxidase promotes
reactivation of Grx2 complex
Previously, Lillig et al. demonstrated that high concentrations of
hydrogen peroxide (10 mM) did not promote dissociation of the
isolated complex of dimeric human recombinant Grx2 with the
iron–sulfur cluster [13]. Likewise we found that treatment of
mitochondrial lysates with H2O2 did not change the Grx activity
(data not shown). On the other hand, the isolated complex can be
dissociated by one-electron donors such as sodium dithionite
only under aerobic conditions; or by one electron acceptors like
ferricyanide [13]. Based on these observations and interpretation
of voltametric dissociation of the complex [64], we hypothesized
that the Grx2 complex could be dissociated also by superoxide,
which can serve either as a one-electron donor or acceptor [43].
To test this hypothesis we used xanthine oxidase to generate
superoxide radicals.
Xanthine oxidase catalyzes the oxidation of xanthine to uric acid,
producing both superoxide and hydrogen peroxide [44], providing the
opportunity to distinguish the effects of hydrogen peroxide and
superoxide. To focus on hydrogen peroxide, liver mitochondrial lysates
were treated with xanthine and xanthine oxidase, along with Mn-
TMPyP (a chemical SOD mimetic). To focus on superoxide, the lysates
were treated with xanthine and xanthine oxidase, along with catalase
(H2O2 scavenger). To demonstrate the effectiveness of the xanthine/
xanthine oxidase systemþROS scavengers, we ﬁrst documented the
reduction of cytochromes c and aa3 (Fig. 5) from liver mitochondrial
lysates. These cytochromes are susceptible to reduction by superoxide
(one-electron donor). We chose the concentration of xanthine oxidase
by conducting separate experiments with isolated cytochrome c to
ﬁnd the minimum concentration of the enzyme (10 μM) that would
facilitate rapid (r3min) and complete reduction of the cytochrome c
(data not shown). As expected, reduction of cytochromes c and aa3was
observed when the mitochondrial lysates were treated with xanthine
and xanthine oxidase, conﬁrming production of adequate superoxide.
This reduction was unchanged by the addition of catalase. Treatment
with Mn-TMPyP, however, inhibited the reduction of the cytochromes,
conﬁrming diminished superoxide concentration.
Using this ROS-generation system, we then examined the
effects of superoxide and hydrogen peroxide on the stability of
the Grx2–iron–sulfur complex in heart mitochondria lysates. The
activity of Grx2 in lysates of heart mitochondria was increased in
the presence of xanthine oxidase to the same extent as treatment
with sodium dithionite, and this activation was not inhibited by
the addition of catalase (Fig. 6). These results indicate that super-
oxide mediates the dissociation of the inactive Grx2 dimer, and
conﬁrms that hydrogen peroxide does not.
Fig. 5. Mitochondrial cytochrome reductions in response to different ROS mole-
cules. Isolated liver mitochondria from young F344 rats were lysed in RIPA buffer
containing GSH (1 mM) and sodium cyanide (NaCN, 5 μM), a cytochrome c oxidase
inhibitor that prevents the reduced form from being re-oxidized. Mitochondria
samples lysed in the presence of GSH were then treated with xanthine (2 mM) and
xanthine oxidase (XO, 10 μM) and either (A) vehicle, (B) catalase (CAT, 1 mg/mL) to
scavenge H2O2 or (C) Mn-TMPyP (40 and 80 μM) to scavenge superoxide anions.
Visible absorbance was recorded from 500 to 660 nm. The reduced forms of
cytochrome c and aa3 have absorbance maxima at 550 and 600 nm, respectively.
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Fig. 6. Modulation of Grx2 activity by ROS produced by the xanthine oxidase
system in vitro. Isolated heart mitochondria from young adult rats were lysed in the
presence of either GSH (1 mM) to maintain the inactive Grx2 complex (white bar),
or sodium dithionite (10 mM, DT) to fully dissociate Grx2 (black bar). Mitochondrial
samples lysed in the presence of GSH were then combined with xanthine oxidase
(XO, 10 μM) to generate superoxide radicals and/or hydrogen peroxide upon
metabolizing xanthine. Also added were either vehicle (diagonal bar), or catalase
(checkered bar; CAT, 1 mg/mL) to selectively scavenge H2O2. The reactions were
initiated by adding xanthine (2 mM), and then Grx2 activity was determined for
each sample, with results reported as nmol/min/mg of mitochondrial protein
(mean7SEM, n¼6).
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Intramitochondrial ROS generation does not promote the dissociation
of Grx2 complex
Complexes I–III of the mitochondrial electron transport chain
produce superoxide that is rapidly converted to hydrogen peroxide
[45–47]. Inhibition of Complex I, such as by rotenone, leads to
increased production of ROS particularly in the mitochondrial
matrix [35]. Therefore we examined the ability of rotenone to
activate Grx2 in situ by promoting intramitochondrial superoxide
formation. The Grx2 activity was little affected by rotenone
treatment of the mitochondria (Fig. 7). With heart mitochondria
from young adult rats rotenone treatment had essentially no effect
on the Grx2 activity (Fig. 7A). With the mitochondria from elderly
rats, there appeared to be a slight increase in Grx2 activity with
rotenone treatment (Fig. 7B), but this effect was not statistically
signiﬁcant (p¼0.46). Treatment of the corresponding lysates with
dithionite, however, still fully activated the Grx2 in both cases
(Fig. 7A and B). These data challenge the concept that Grx2
deglutathionylase activity may be responsive to oxidative stress
in vivo (see Discussion section).
Discussion
Changes in protein thiol-disulﬁde homeostasis in heart mitochondria
from elderly animals
Intracellular redox homeostasis is tightly controlled by thiol-
reducing enzymes, particularly two thiol-disulﬁde oxidoreductase
enzyme systems: thioredoxin (Trx) and glutaredoxin (Grx). Both
enzymes regulate thiol-disulﬁde status of cysteine residues on
various proteins essential for many important cell functions,
including the balance between cell survival and death [20,48,49].
Our previous studies found that diminution of cytosolic Grx1 in
hearts of elderly rats contributes to an increase in the suscept-
ibility of cardiomyocytes to oxidant-induced apoptosis through
dysregulation of NF-κB activity [18]. We have now extended our
study to learn that mitochondrial Grx1 and Grx2, but not thior-
edoxin and thioredoxin reductase, or GSSG reductase, are altered
differently by age in Fischer 344 rat hearts. Another research group
previously reported data for TR2 in this context [50]. Like our
ﬁndings, they also reported no change in TR2 in IFM. Their value
for TR2 activity in SSM from young adult rats also was very similar
to our value (Table 2); however, in contrast to our ﬁnding of no
change, they reported a doubling of TR2 activity in SSM from the
elderly F344 rats. The basis for this discrepancy is unknown.
Diminution of Grx1 in the hearts of elderly animals
Glutaredoxin is the primary enzyme responsible for catalyzing
deglutathionylation of protein-S-glutathione mixed disulﬁdes in
mammalian cells [51,52]. In the heart, the activity of Grx1
corresponds to its content in both the cytosol and the IMS,
indicating that Grx1 exists in its active form throughout the
cardiomyocytes. The contents of Grx1 in the cytosol and IMS
decrease to about the same extent in elderly animals, suggesting
that Grx1 in the IMS is equilibrated with that of the cytosolic
counterpart across the outer membrane of mitochondria. The
mechanism by which Grx1 is imported into the IMS is still
unknown, but our current results suggest that similar or linked
regulatory mechanisms control the level of Grx1 in both cellular
compartments.
Since mitochondria are an essential organelle for initiation and
activation of apoptosis [53,54], the age-associated diminution of
Grx1 deglutathionylase activity in the IMS may contribute to the
increased susceptibility to apoptosis of cardiomyocytes from the
elderly [18]. Pertinent to this consideration, a number of proteins
associated with the IMS have been reported to be susceptible to
alterations in function by glutathionylation in vitro or in vivo
[53,55]. For example, glutathionylation of exposed cysteines
on components of Complex I (75 kDa subunit) and Complex II
(succinate ubiquinone reductase) leads to aberrant generation of
ROS and impaired respiratory function [55]. Moreover, the IMS
appears to be under higher oxidative stress (compared to the
cytosol and mitochondrial matrix) due to ROS from the electron
transport chain and limited diffusion of GSH across the outer
membrane [56]. Thus, loss of Grx1, apparently the sole deglu-
tathionylase in the IMS, could lead to alterations in mitochondrial
membrane potential, initiation of apoptotic signaling due to
inhibition of respiratory chain or modiﬁcation of proteins asso-
ciated with the mitochondrial permeability transition pore [55],
increased production of ROS, and interference with normal mito-
chondrial signaling. Additional studies are necessary to learn how
Grx1 is decreased with aging and to distinguish among the many
potential consequences of Grx1 diminution within the IMS.
Increased Grx2 in heart mitochondrial matrix of elderly animals
In contrast to Grx1, the content of Grx2 was increased in the
matrix fraction of heart mitochondria from the elderly rats (Fig. 3).
The mechanism by which the nuclear-encoded Grx2 is upregu-
lated as a result of aging is unknown, providing an intriguing topic
for future studies. The mitochondrial matrix deglutathionylase
activity was much less than predicted according to the content of
Grx2 and the known speciﬁc activity of the isolated monomeric
Fig. 7. Inhibition of Complex I (intramitochondrial production of ROS) does not lead
to Grx2 activation. Isolated intact heart mitochondria from (A) young adult and
(B) elderly rats were incubated with glutamate (20 mM) in the absence (white bar)
or presence (black bar) of rotenone (7.5 μM) for 25 min. The treated mitochondria
were lysed in RIPA buffer with either GSH (1 mM, bar design) or sodium dithionite
(10 mM, DT, diagonal bar). Grx2 activity in each sample was then determined,
reported as nmol/min/mg of mitochondrial protein (mean7SEM, n¼3–5).
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enzyme. An inactive dimeric Grx2 complex with an iron–sulfur
cluster has been characterized [13,41,57], but the in situ activity of
Grx2 has not been assessed previously. We hypothesized that the
lower than predicted activity of Grx2 is due to its involvement in
the inactive dimeric complex in the mitochondrial matrix. To test
this hypothesis, we treated mitochondrial lysates with sodium
dithionite, which has been shown to dissociate human recombi-
nant Grx2 from the iron–sulfur cluster complex in vitro [13]. We
observed that the predicted activity of Grx2 in mitochondrial
lysates was fully recovered by this treatment. In contrast, lysis of
the mitochondria in the presence of GSH gave a preparation with
low deglutathionylase activity—presumably by preserving the
dimeric Grx2/iron–sulfur complex as it exists in situ. Accordingly,
we conclude that a majority of the Grx2 exists as the inactive
complex in the mitochondrial matrix. Nevertheless, there is a net
increase in Grx2 deglutathionylase activity in the mitochondria
from the elderly compared to the young adult animals (Fig. 4),
suggesting an adaptive response to the oxidative stress associated
with aging. However, the increase in activity is substantially
smaller for the IFM because less of the total Grx2 in the IFM from
the elderly rats is in the active form compared to the young adult
animals. The relative diminution in deglutathionylase activity of
Grx2 in the IFM may be a contributing factor to the greater
sensitivity of IFM from the elderly to ischemia–reperfusion
damage [6]. As discussed above for Grx1, discerning the relation-
ship between the net deglutathionylase activity of Grx2 in the
matrix and the status of S-glutathionylation of particular matrix
proteins is a keen objective of future studies.
Potential role of ROS in activating Grx2 in the mitochondrial matrix
To examine whether the inactive Grx2 complex could be
dissociated and reactivated in response to ROS production both
in vitro and in vivo, we ﬁrst tested the effects of xanthine oxidase,
which generates superoxide and hydrogen peroxide. Adding
catalase or a superoxide scavenger allowed us to distinguish the
individual effects of superoxide or H2O2, respectively. The full
activity of Grx2 could be realized with superoxide, but not with
hydrogen peroxide. Since inhibition of Complex I of the mitochon-
drial electron transport chain is known to generate superoxide
into the matrix [22,58], we tested the effect of treatment of the
mitochondria with the Complex I inhibitor rotenone on the
deglutathionylase activity of the matrix fraction (Grx2). Little to
no activation of Grx2 was seen with rotenone treatment (Fig. 7).
Either insufﬁcient superoxide is formed in response to rotenone,
or the superoxide is converted too rapidly to hydrogen peroxide
(spontaneously or viaMn-SOD which is localized to the mitochon-
drial matrix [35,48,59]. These results suggest that the inactive
Grx2 dimer is unlikely to be dissociated to enhance the deglu-
tathionylase in response to ROS generation in mitochondria under
stress conditions in vivo, unless the insult (e.g., ischemia/reperfu-
sion) generates more superoxide in a sustained fashion than what
rotenone treatment does. It is conceivable that unique spatial and
temporal regulatory strategies may exist to ensure tight regulation
of dimeric Grx2 by superoxide. This would allow superoxide to
function locally even in the presence of antioxidant enzymes and
GSH, as previously discussed [60–62].
Mechanism of dissociation of the dimeric Grx2–iron–sulfur complex
Previous studies of other iron–sulfur proteins have demon-
strated dissociation of the complex through a one-electron oxida-
tion of Fe2þ (reduced) to Fe 3þ (oxidized) [63,64]. We hypothesize
that dissociation of the dimeric Grx2 complex by superoxide
occurs analogously (Scheme 1).
This hypothesis is supported by previous observations. As
noted, Lillig et al. [13] reported that ferricyanide (one-electron
oxidant) and dithionite (one-electron reductant) both dissociated
the dimeric Grx2 complex under aerobic conditions. This action of
dithionite appears confusing at ﬁrst because the Fe(II) of the
cluster would not be expected to be reduced further; i.e., Fe(I) is
not a typical redox state of iron. The interpretation is clariﬁed by
another study that showed dithionite does not dissociate an
analogous dimeric Grx–iron–sulfur complex under anaerobic con-
ditions [39].Therefore the most likely mechanism by which
dithionite promotes dissociation of the dimeric Grx2 complex is
by donating an electron to molecular oxygen to form superoxide
which then acts as a one electron oxidant as shown in Scheme 1.
This conclusion is supported also by previous studies that docu-
mented formation of radicals (superoxide) when dithionite was
added to aqueous solutions under aerobic conditions [65–67].
Our results suggest that the slightly increased concentration of
GSSG that would be induced by rotenone does not promote the
dissociation of the Grx2 complex, likely due to the relatively high
GSH content in the mitochondrial matrix which stabilizes the
cluster complex. Previous studies have shown that high concen-
tration of GSSG alone can lead to the dissociation of the isolated
iron–sulfur cluster complex with recombinant human Grx2 [13].
However, the physiological relevance of these experimental con-
ditions is questionable, because even under extreme oxidative
stress conditions, the ratio of GSH and GSSG among all intracel-
lular compartments likely does not fall below 1:1, as compared
to 100:1 under normal conditions [68,69].
Alternative functions of Grx2
A role for Grx2 in cellular redox control during cell apoptosis,
particularly under oxidative stress conditions, has been documen-
ted in previous studies. For example, depletion of Grx2 by selective
knockout or knockdown in various cell types increases their
susceptibility to apoptosis in response to oxidant insults [70,71].
In comparison, the overexpression of Grx2 in HeLa cells, cardio-
myocytes and neurons has been found to be protective against
apoptotic stimuli [21,72,73]. Therefore it is important to under-
stand how Grx2 regulates speciﬁc apoptotic signaling pathways
under oxidative stress conditions. Grx2 has dual functionality:
deglutathionylase activity and the ability to bind an iron–sulfur
cluster. For example, Grx2 is shown to catalyze deglutathionyla-
tion of the 75 kDa subunit of Complex I and restore activity, which
is important for maintaining the integrity of the electron transport
chain [70]. However, our results revealed that the majority of Grx2
in situ is inactive as a deglutathionylase under basal conditions and
does not appear to be reactivated in response to a model oxidative
stress insult (rotenone). These observations suggest that the
primary physiological function of Grx2 may not relate to its
enzymatic deglutathionylase activity. Accordingly, siRNA knock-
down of Grx2 leads to decreased incorporation of iron into
mitochondrial [Fen–Sn] proteins and corresponding loss of activity,
e.g., Complex I and aconitase [74], suggesting that the Grx2 iron–
sulfur cluster complex may function as a shuttle to transfer [FenSn]
clusters to apo-targeted proteins in mitochondria. In our current
study a signiﬁcant increase of the Grx2 dimer was observed in the
elderly, corresponding to a concomitant increase in associated
iron–sulfur clusters. This ﬁnding suggests that the increased level
Scheme 1. Proposed mechanism of dissociation of the dimeric Grx2–iron–sulfur
complex by superoxide.
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of Grx2-linked iron–sulfur clusters may contribute in part to iron
accumulation in the hearts of elderly rodents reported previously
[75,76]. Further studies are necessary to distinguish whether
mitochondrial Grx2 plays a more important role in iron–sulfur
homeostasis than in sulfhydryl homeostasis.
Concluding remarks
A link between mitochondrial dysfunction and age-associated
oxidative stress has been proposed previously [77], but how this
dysregulation of mitochondrial redox hemostasis contributes to, or
results from, the aging process remains unresolved [78]. Previous
studies have shown that the IFM and SSM have distinct biochem-
ical and functional differences, particularly with age [6]. The
results of our current study demonstrate that both subpopulations
exhibit a similar diminution of Grx1 content and activity with age,
concomitant with an analogous diminution in cytosolic Grx1. The
loss of cytosolic Grx1 was linked to diminution of NF-κB activity
and decreased anti-apoptotic gene expressions [18]. The concomi-
tant loss of Grx1 in the IMS may further exacerbate sensitivity to
oxidant induced apoptosis by decreasing homeostatic regulation
of the thiol status of proteins associated with the mitochondrial
permeability transition pore, leading to cytochrome c release. In
contrast to Grx1, we found Grx2 content was increased in the
matrix of both SSM and IFM from the hearts of elderly rats, but the
decreased deglutathionylase activity of the IFM matrix fraction
indicated higher levels of dimeric Grx2–iron–sulfur cluster com-
plex as compared to the SSM. This ﬁnding suggests an adaptation
of iron homeostasis in the IFM correlated with age. However,
accumulation of iron in mitochondria can induce ROS production
via Fenton chemistry, which results in an increase in production of
hydroxyl radical (OH  ), the most damaging free radical capable
of oxidizing macromolecules and damaging cells [79]. This may
explain in part why the IFM from the elderly rats display higher
levels of oxidative stress and age-related heart dysfunction [33].
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